| Literature DB >> 32098176 |
Di Wang1, Shilei Zhu1, Lijing Wang1, Qing Zhen2,3, Fengpeng Han2,3, Xingchang Zhang2,3,4.
Abstract
The Loess Plateau has one of the most vulnerable ecological environments in the world, but it also contains abundant oil and gas resources that are regularly exploited, which has resulted in serious environmental problems. Therefore, it is important to analyze the polycyclic aromatic hydrocarbons (PAHs) present in the topsoil of this region. The ∑16PAHs concentrations between 1980-1999 and 2000-2019 ranged from 1134.20-15871.04 and 1010.67-18,068.80 µg kg-1, with average values of 5021.30 and 5662.82 µg kg-1. All samples displayed heavy pollution levels according to European soil quality standards. In addition, among the measured physicochemical properties, the soil organic carbon (SOC) had the greatest influence on PAHs, while soil particle size distribution had the smallest effect. Source apportionment indicated that the two main sources were petroleum source (37.57%) and vehicular traffic source (25.88%). Lastly, an assessment of the carcinogenic risks illustrated that more focus should be placed on the dermal pathway in which the human body is exposed to soil PAHs. Overall, the carcinogenic risks in different populations did not exceed 10-4, but there was still a potential carcinogenic risk in some age groups, especially in adult women.Entities:
Keywords: PAHs; PMF; distribution; human health risk; sources
Year: 2020 PMID: 32098176 PMCID: PMC7068613 DOI: 10.3390/ijerph17041390
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Map of the study area.
Concentration profiles of PAHs in soil samples (μg kg−1).
| Compounds | 1980–1999 | 2000–2019 | ||||
|---|---|---|---|---|---|---|
| Mean | Median | Range | Mean | Median | Range | |
| NAP | 125.06 | 105.08 | 64.46–196.55 | 106.54 | 93.35 | 66.13–173.61 |
| ACY | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. |
| ACE | 92.76 | 67.08 | N.D.–157.98 | 117.35 | 129.18 | N.D.–148.78 |
| FLU | 447.80 | 160.88 | 78.05–1665.20 | 471.17 | 178.38 | 44.48–2383.70 |
| PHE | 1857.66 | 770.92 | 200.39–6836.28 | 2027.13 | 1709.03 | 127.81–8052.24 |
| ANT | 361.96 | 56.82 | N.D.–1317.29 | 247.27 | 123.33 | N.D.–1238.50 |
| FLA | 167.70 | 101.15 | 48.14–517.14 | 301.39 | 291.39 | 23.09–867.22 |
| PYR | 274.51 | 146.45 | 82.95–872.94 | 366.73 | 358.11 | 34.62–818.16 |
| BaA | 58.72 | 35.56 | N.D.–136.92 | 82.11 | 73.25 | 4.20–185.51 |
| CHR | 1287.65 | 493.29 | 296.07–3340.34 | 1357.79 | 1226.35 | 116.65–3796.53 |
| BbF | 189.04 | 150.16 | 48.07–449.25 | 244.37 | 185.32 | 27.08–572.11 |
| BkF | 18.04 | 18.55 | N.D.–21.09 | 35.50 | 28.15 | N.D.–67.05 |
| BaP | 100.91 | 82.55 | N.D.–214.56 | 96.00 | 73.11 | N.D.–225.40 |
| InP | 44.69 | 56.53 | N.D.–71.32 | 74.97 | 58.65 | N.D.–151.52 |
| DBA | 42.28 | 42.28 | N.D.–55.69 | 65.33 | 67.69 | N.D.–102.03 |
| BgP | 180.53 | 185.63 | N.D.–294.00 | 227.11 | 217.56 | 65.30–433.26 |
| ∑16PAHs | 5021.30 | 1968.79 | 1134.20–15,871.04 | 5662.82 | 5418.25 | 1010.67–18,068.80 |
| ∑7PAHs | 1658.93 | 753.88 | 370.96–4214.10 | 1877.19 | 1950.37 | 223.96–4642.40 |
| ∑LMWPAHs | 2775.74 | 1112.14 | 449.01–10,008.86 | 2890.40 | 2430.40 | 307.07–11,805.44 |
| ∑HMWPAHs | 2245.56 | 1114.75 | 527.78–5862.18 | 2772.41 | 2614.66 | 544.86–6263.36 |
∑16PAHs—summation of concentrations of sixteen PAHs. ∑7PAHs—summation of concentrations of seven carcinogenic PAHs including BaA, CHR, BbF, BkF, BaP, DBA, and InP. ∑LMWPAHs—the concentration sum of low molecular weight PAHs (2–3 rings). ∑HMWPAHs—the total concentrations of high molecular weight PAHs (≥4 rings). All the other abbreviations used are explained in Supplementary Table S1. N.D.—Not Detected.
Figure 2Concentrations of PAHs in soil samples.
Figure 3Triangular diagram of percentage concentrations for 16PAHs in soil samples.
Figure 4Principal component analysis (PCA) of the correlation between PAHs and soil physicochemical properties. All the PAHs abbreviations used are explained in Supplementary Table S1.
Figure 5Results of the Positive Matrix Factorization (PMF) model: (a) Source profiles of each PMF factor and (b) percentage source contributions of each factor to total PAHs. All the PAHs abbreviations used are explained in Supplementary Table S1.
The ILCRs of people for different exposure pathways.
| Exposure Pathway | 1980–1999 | 2000–2019 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |||
| Child | Male | Min | 2.91 × 10−7 | 3.63 × 10−7 | 6.15 × 10−12 | 6.54 × 10−7 | 1.33 × 10−7 | 1.66 × 10−7 | 2.82 × 10−12 | 3.00 × 10−7 |
| Max | 1.74 × 10−6 | 2.17 × 10−6 | 3.67 × 10−11 | 3.91 × 10−6 | 2.15 × 10−6 | 2.68 × 10−6 | 4.55 × 10−11 | 4.83 × 10−6 | ||
| Mean | 8.54 × 10−7 | 1.06 × 10−6 | 1.81 × 10−11 | 1.92 × 10−6 | 9.91 × 10−7 | 1.24 × 10−6 | 2.09 × 10−11 | 2.23 × 10−6 | ||
| Female | Min | 2.99 × 10−7 | 3.73 × 10−7 | 6.33 × 10−12 | 6.72 × 10−7 | 1.37 × 10−7 | 1.71 × 10−7 | 2.90 × 10−12 | 3.08 × 10−7 | |
| Max | 1.79 × 10−6 | 2.23 × 10−6 | 3.78 × 10−11 | 4.02 × 10−6 | 2.21 × 10−6 | 2.76 × 10−6 | 4.67 × 10−11 | 4.97 × 10−6 | ||
| Mean | 8.78 × 10−7 | 1.09 × 10−6 | 1.86 × 10−11 | 1.97 × 10−6 | 1.02 × 10−6 | 1.27 × 10−6 | 2.15 × 10−11 | 2.29 × 10−6 | ||
| Adolescent | Male | Min | 1.74 × 10−7 | 4.33 × 10−7 | 1.19 × 10−11 | 6.06 × 10−7 | 7.95 × 10−8 | 1.98 × 10−7 | 5.46 × 10−12 | 2.78 × 10−7 |
| Max | 1.04 × 10−6 | 2.58 × 10−6 | 7.11 × 10−11 | 3.62 × 10−6 | 1.28 × 10−6 | 3.20 × 10−6 | 8.80 × 10−11 | 4.48 × 10−6 | ||
| Mean | 5.09 × 10−7 | 1.27 × 10−6 | 3.50 × 10−11 | 1.78 × 10−6 | 5.91 × 10−7 | 1.47 × 10−6 | 4.05 × 10−11 | 2.06 × 10−6 | ||
| Female | Min | 1.79 × 10−7 | 4.47 × 10−7 | 1.23 × 10−11 | 6.27 × 10−7 | 8.22 × 10−8 | 2.05 × 10−7 | 5.64 × 10−12 | 2.87 × 10−7 | |
| Max | 1.07 × 10−6 | 2.67 × 10−6 | 7.35 × 10−11 | 3.74 × 10−6 | 1.33 × 10−6 | 3.30 × 10−6 | 9.10 × 10−11 | 4.63 × 10−6 | ||
| Mean | 5.26 × 10−7 | 1.31 × 10−6 | 3.61 × 10−11 | 1.84 × 10−6 | 6.11 × 10−7 | 1.52 × 10−6 | 4.19 × 10−11 | 2.13 × 10−6 | ||
| Adult | Male | Min | 3.16 × 10−7 | 5.61 × 10−7 | 2.14 × 10−11 | 8.77 × 10−7 | 1.45 × 10−7 | 2.57 × 10−7 | 9.81 × 10−12 | 4.02 × 10−7 |
| Max | 1.89 × 10−6 | 3.35 × 10−6 | 1.28 × 10−10 | 5.24 × 10−6 | 2.33 × 10−6 | 4.14 × 10−6 | 1.58 × 10−10 | 6.48 × 10−6 | ||
| Mean | 9.26 × 10−7 | 1.65 × 10−6 | 6.29 × 10−11 | 2.57 × 10−6 | 1.07 × 10−6 | 1.91 × 10−6 | 7.29 × 10−11 | 2.98 × 10−6 | ||
| Female | Min | 3.43 × 10−7 | 6.10 × 10−7 | 2.33 × 10−11 | 9.53 × 10−7 | 1.57 × 10−7 | 2.79 × 10−7 | 1.07 × 10−11 | 4.37 × 10−7 | |
| Max | 2.05 × 10−6 | 3.64 × 10−6 | 1.39 × 10−10 | 5.69 × 10−6 | 2.54 × 10−6 | 4.50 × 10−6 | 1.72 × 10−10 | 7.04 × 10−6 | ||
| Mean | 1.01 × 10−6 | 1.79 × 10−6 | 6.84 × 10−11 | 2.80 × 10−6 | 1.17 × 10−6 | 2.08 × 10−6 | 7.93 × 10−11 | 3.24 × 10−6 | ||